Nektar Therapeutics (NKTR)
57.74
-1.04
(-1.77%)
USD |
NASDAQ |
Dec 10, 16:00
57.24
-0.50
(-0.87%)
After-Hours: 06:02
Nektar Therapeutics Market Cap: 998.93M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 889.33B |
| Amicus Therapeutics, Inc. | 3.039B |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| Rigel Pharmaceuticals, Inc. | 748.20M |
| Zevra Therapeutics, Inc. | 475.71M |
Market Cap Related Metrics
| PS Ratio | 59.54 |
| PEG Ratio | -0.0285 |
| Price to Book Value | 11.74 |
| Price | 57.74 |
| Earnings Yield | -7.90% |
| PEGY Ratio | -0.0285 |